好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Powassan Virus Infection Presenting as Rapidly Progressive Encephalitis and New-onset Refractory Status Epilepticus (NORSE)
Infectious Disease
P10 - Poster Session 10 (11:45 AM-12:45 PM)
13-009
NA

Powassan virus is a rare tick-born illness that may cause meningitis and encephalitis. There are several areas of the country where Powassan virus has been identified including the Northeast and Great Lakes Region. We present a case of Powassan encephalitis in a 74-year-old female employed as a dog-walker with rapid neurological decline secondary to NORSE.

NA

Patient first presented with headaches, fatigue, unsteady gait, and clumsiness. Preliminary CT was unrevealing, and she was placed on the stroke pathway. On day 2, she developed acute fevers, hypersomnolence, and confusion. Was then witnessed to have generalized seizure activity. She required multiple rounds of benzodiazepines, intubation, and sedation to stop seizures. On video EEG monitoring, she was noted to be in non-convulsive status epilepticus. Her seizures remained difficult to control despite 4 anti-epileptic agents and sedation. MRI identified bilateral T2/FLAIR hyperintensities without diffusion restriction in the bilateral basal ganglia, thalami, and midbrain. Follow up MRI on day 8 revealed more extensive T2/FLAIR changes as well as new diffusion restriction of unclear etiology but suspected to be either infectious or inflammatory.  CSF studies were notable for elevated protein and HHV-6 IgM antibodies and was empirically treated with Ganciclovir. Further CSF studies resulted positive for Powassan virus which was also confirmed on serum studies. She was empirically treated with pulse-dose steroids and plasmapheresis but unfortunately had no significant improvement. At that point, her family chose to proceed with comfort-directed care until she passed.


While neuroinvasive Powassan virus remains a rare disease process, it should be considered on the differential for patients with NORSE in an endemic tick region. Additionally, it should be considered with isolated T2/FLAIR changes without diffusion restriction, particularly when the deep white matter structures are involved.
Authors/Disclosures
Jenifer Moceri, DO
PRESENTER
Dr. Moceri has nothing to disclose.
Krima Patel, DO (St. Luke's Anderson Campus GME Office) Dr. Patel has nothing to disclose.
Cory P. Hackmyer, DO Dr. Hackmyer has nothing to disclose.
Jennifer Axelband, DO (St. Luke's University Hospital) Dr. Axelband has nothing to disclose.